Granahan Investment Management - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 448 filers reported holding REPLIGEN CORP in Q1 2022. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$21,109,850
-1.0%
132,758
-11.9%
0.75%
+14.6%
Q2 2023$21,328,207
+14.0%
150,772
+35.7%
0.66%
+15.3%
Q1 2023$18,711,530
+2.6%
111,140
+3.2%
0.57%
+2.2%
Q4 2022$18,228,930
+44.7%
107,666
+59.9%
0.56%
+35.5%
Q3 2022$12,597,000
-37.2%
67,322
-45.5%
0.41%
-40.0%
Q2 2022$20,044,000
+354.0%
123,422
+425.8%
0.68%
+522.7%
Q1 2022$4,415,000
+456.0%
23,475
+490.4%
0.11%
+633.3%
Q2 2021$794,000
-88.8%
3,976
-89.1%
0.02%
-90.1%
Q1 2021$7,101,000
+38.9%
36,528
+36.9%
0.15%
+31.3%
Q4 2020$5,113,000
-73.3%
26,681
-79.5%
0.12%
-82.3%
Q3 2020$19,173,000
-10.0%
129,950
-22.3%
0.65%
-15.5%
Q2 2020$21,300,000
+8.6%
167,231
-17.7%
0.77%
-27.1%
Q1 2020$19,609,000
-12.3%
203,114
-16.0%
1.06%
+2.6%
Q4 2019$22,354,000
+20.1%
241,666
-0.4%
1.03%
+0.5%
Q3 2019$18,612,000
-15.3%
242,688
-5.1%
1.02%
-5.7%
Q2 2019$21,982,000
+33.9%
255,755
-7.9%
1.09%
+23.3%
Q1 2019$16,412,000
+17.1%
277,796
+4.5%
0.88%
-11.3%
Q4 2018$14,018,000
-5.4%
265,802
-0.6%
0.99%
+23.5%
Q3 2018$14,825,000
+76.9%
267,316
+50.0%
0.80%
+59.2%
Q2 2018$8,381,000
+45.8%
178,159
+12.1%
0.50%
+21.7%
Q1 2018$5,750,000
+433.9%
158,929
+435.1%
0.42%
+388.2%
Q4 2017$1,077,00029,6990.08%
Other shareholders
REPLIGEN CORP shareholders Q1 2022
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders